I am not a doctor and the same person, like many others, we rely on the facts that are provided to us via the Internet (trust or not) It doesn't matter to me, to be honest, I don't care who is right and who is not. I am a man of my principles and justice so that everything is within the framework of morality and ethics! It is difficult for me to judge the situation about the Corona or the Flu as I was ill the last time in 1994 or 1997, I do not remember exactly. I draw conclusions only because of the opinions of other people with whom I am connected. As I described earlier, I work with a lot of people.
Merry Christmas to all of you! Thank you for your time discussing with me. Always refreshing regardless of who it is / was. I always enjoy. Enjoy holidays! BTW Just spotted another drug that looks promising. Ivermectin And to all who are scientifically interested I'd suggest to have a look on youtube channel Drbeen Medical Lectures. And he's also a detailed subject for @gorski 'long haulers' very interesting. Also the GB mutation. Be aware he's very detailed. I'll take a short break, but will respond soon to the posts. Cya.
Indeed, Merry Christmas to all! OMG -- I know someone who has been taking that for most of the last year, in his case he thinks it's a cure against prostate cancer. He got COVID 2 weeks ago, by the way... but he recovered. He did have intense pain in chest and back and the symptoms kind of came in waves for him, good days and bad days.
Ivermectin is a well known antiparasitic employed with success in Latin America. Yet not as successful by chance as chlorine dioxide. But yes they say it's a good solution. Remember chlorine dioxide is a powerful biocide.
>Remember chlorine dioxide is a powerful biocide. So are naplam , dyoxin , uranium , xylon B and glyphosate .
First of all, Merry Christmas, and secondly, wow...your post is almost a year old and so much has changed since then with respect to CV19. How are you doing? What's happening is Germany? In the USA over 300,000 people have been lost to this wicked virus. Apart from staying at home and waiting to be vaccinated, do the usual stuff which you are probably tired of hearing about, such as: wear a mask (at least a level2 type), practice social distancing, and wash your hands frequently. Hope all is well with you. Stay safe.
Here's a couple of articles on IIvermectin: https://www.researchsquare.com/article/rs-100956/v2 https://assets.researchsquare.com/files/rs-100956/v1/682247ca-ef49-4d68-aa3f-493a8fc9a056.pdf .
Ivermectin is getting attention now, lol as expected. Being a patented substance makers are going to make lots of money.
According to scientists, the supposed "new strain" in England would be the effect of the Pfizer vaccine. In 5 days 3,150 people had serious problems. 3% already in the first week. They were the first to be vaccinated and they are the ones who have their side effects first: covid-21 OFFICIAL DATA: https://www.cdc.gov/vaccines/acip/m...sWDRndDt77rQGKPelSnhKkwv0IY7Et4HwhWt8xbEXhjhU
They're saying polyethylene glycol is causing this, which apparently is a "compound in the packaging of the messenger RNA (mRNA) that forms the vaccine’s main ingredient". And the Moderna vaccine uses it, too. That sucks.
Farmafia = criminals within the law Pharmafia = Big Pharma Vaccines = Death disguised as Savior Hey but don't listen to me. I'm a f conspiraloonie. Much less chlorine dioxide, I must be completely insane.
Remember, the complication is rare. If pharma intended this effect, they would have made it common. Flu vaccines prevent many bouts of flu each year, preventing deaths from flu. It is not death disguised, but maybe not quite savior either.
https://www.theguardian.com/world/2...tm_source=esp&utm_medium=Email&CMP=GTUK_email UK scientists trial drug to prevent infection that leads to Covid Exclusive: Antibody therapy could confer instant immunity to Covid-19 on at-risk groups A ventilated coronavirus patient: doctors hope the antibody therapy can be given to inpatients. Denis Campbell Health policy editor Fri 25 Dec 2020 17.00 GMT Last modified on Sat 26 Dec 2020 10.40 GMT British scientists are trialling a new drug that could prevent someone who has been exposed to coronavirus from going on to develop the disease Covid-19, which experts say could save many lives. The antibody therapy would confer instant immunity against the disease and could be given as an emergency treatment to hospital inpatients and care home residents to help contain outbreaks. People living in households where someone has caught Covid could be injected with the drug to ensure they do not become infected too. It could also be given to university students, among whom the virus has spread rapidly because they live, study and socialise together. Dr Catherine Houlihan, a virologist at University College London Hospitals NHS trust (UCLH) who is leading a study called Storm Chaser into the drug, said: “If we can prove that this treatment works and prevent people who are exposed to the virus going on to develop Covid-19, it would be an exciting addition to the arsenal of weapons being developed to fight this dreadful virus.” The drug has been developed by UCLH and AstraZeneca, the pharmaceutical company that has also, along with Oxford University, created a vaccine that the Medicines and Healthcare products Regulatory Agency is expected to approve for use in Britain next week. The team hope the trial shows that the cocktail of antibodies protects against Covid-19 for between six and 12 months. Trial participants are receiving it as two doses, one after the other. If it is approved, it would be offered to someone who has been exposed to Covid in the previous eight days. It could be available as soon as March or April if it is approved by the medicines regulator after it has reviewed evidence from the study. The trial involves UCLH, several other British hospitals and a network of 100 sites globally. This month University College hospital became the first site in the world to recruit patients into the randomised control trial and give them the jab or a placebo. “To date we have injected 10 participants – staff, students and other people – who were exposed to the virus at home, in a healthcare setting or student halls,” said Houlihan. She and colleagues would closely follow the participants to see which of them develop Covid-19. The immediate protection that the drug promises could play a vital role in reducing the impact of the virus until everyone has been immunised. The vaccination programme is under way using the Pfizer/BioNTech jab and is expected to take until next summer. NHS England accelerated the vaccine deployment this week after criticism from hospital bosses, GP leaders and the former health secretary Jeremy Hunt that it was taking too long. “The advantage of this medicine is that it gives you immediate antibodies,” Houlihan said. “We could say to trial participants who have been exposed: yes, you can have the vaccine. But we wouldn’t be telling them that would protect them from the disease, because it’s too late by then [because the Pfizer and Oxford vaccines do not confer full immunity for around a month].” Paul Hunter, a professor of medicine at the University of East Anglia who specialises in infectious diseases, said the new treatment could significantly reduce the death toll from Covid. “If you are dealing with outbreaks in settings such as care homes, or if you have got patients who are particularly at risk of getting severe Covid, such as the elderly, then this could well save a lot of lives. Providing it’s borne out in phase 3 trials, it could play a big role in keeping alive people who would otherwise die. So it should be a big thing,” he said. “If you had an outbreak in a care home, you might want to use these sorts of cocktails of antibodies to bring the outbreak under control as soon as possible by giving the drug to everybody in the care home – residents and staff – who hasn’t been vaccinated. Similarly, if you live with your elderly grandmother and you or someone else in the house gets infected, then you could give her this to protect her.” The drug involves a long-acting antibody combination known as AZD7442, which has been developed by AstraZeneca. Rather than antibodies produced by the body to help fight an infection, AZD7442 uses monoclonal antibodies, which have been created in a laboratory. In documents on a clinical trial that AstraZeneca has registered in the US, it explains that it is investigating “the efficacy of AZD7442 for the post-exposure prophylaxis of Covid-19 in adults. The Sars-CoV-2 spike protein contains the virus’s RBD [receptor-binding domain], which enables the virus to bind to receptors on human cells. By targeting this region of the virus’s spike protein, antibodies can block the virus’s attachment to human cells, and therefore is expected to block infection.” In a separate trial, called Provent, UCLH is investigating whether the drug could also protect people with compromised immune systems, such as those undergoing chemotherapy for cancer, who have recently been exposed to the virus but have either not had a vaccine or in whom it has not resulted in immunity because of their underlying condition. Both the Provent and Storm Chaser trials are now in phase 3. Dr Nicky Longley, an infectious diseases consultant at UCLH, who is leading the second study, said: “We will be recruiting people who are older or in long-term care, and who have conditions such as cancer and HIV which may affect the ability of their immune system to respond to a vaccine. We want to reassure anyone for whom a vaccine may not work that we can offer an alternative which is just as protective.” Both trials are being undertaken at UCLH’s new vaccine research centre, which is funded by the NHS’s research arm, the National Institute for Health Research, and led by Prof Vincenzo Libri. Dr Richard Jarvis, a co-chair of the British Medical Association’s public health medicine committee, said: “For the vast majority of the population, vaccination offers the best protection against Covid-19, and NHS staff are working around the clock to administer this to as many vulnerable patients as possible in this first rollout wave. “It’ll certainly be interesting to see if these trials are effective. But it’s important that any new treatments are thoroughly researched, scrutinised and, most importantly, safe before we consider introducing them.”
Capitalism and in particular adversarial, neo-liberal model of it has failed!!! This is how Humans are at their best - co-operating, pouring resources into constructive purposes!!! The things we could do if.... https://www.theguardian.com/commentisfree/2020/dec/25/scientists-covid-studies-vaccine-2020 And in the UK almost no one even knows of prof. Djikic and Goethe Institute (Frankfurt), the Team that figured out how the virus propagates and immediately published its findings in the Open Source spirit of co-operation and spreading, sharing the knowledge, as the Spirit that unites, not divides, as neo-liberal dogma would have us at each other's throats all the time! I bet the open community spirit of publicly funded scientists have made it possible but.... maybe one day somebody would actually demonstrate how this works... I know they invited prof. Djikic to the US, he went there, shared his Team's findings, they even wanted to poach him but he remained firm and stayed on as the head of the Team... Hat down!!!
@parafer You might want to google about 'The Swedish Way', to get an own impression. It basically covers lots of things I also posted when being asked what I think what's right. It's not static, they learned from former mistakes (actually every nation had made mistakes). Their strategy is not primarily made to focus on mass vaccination. (I assume they have enough from Pandemrix when they had swine flu). It's based on commands and insight and own responsibility instead of punishment. Also no general lockdowns. But it is FAR away from getting naturally and freely 'herd immunity'. They're actively intervening and protecting- Ivermectin has already lost single patent protection. It's common law that drugs are losing it after a period of time in order to have cheap generics made by competitors. The GB strain is scientifically (sequence) determined and has nothing to do with vaccination. I also had a look at the GB mutation. It's reasonable that the vaccines are still working. There might be a few antibodies which do not work anymore (if they bind to the epitopes that consist of mutated parts), but there are still lots who are doing. What definitely will stop working are monoclonal antibodies who have the special target that has mutated at the S-protein. The huge amount of adverse effects and if they are in a healthy relation to benefit is another topic. Also since you provoke an immune answer by vaccination you'll get 'symptoms' more or less... I rather think it's the nano lipids that cause the allergic reactions.